Skip to main content

Table 1 Clinical characteristics of study subjects at base line and after 5 weeks of ω-3 PUFAs supplementation

From: Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome

  Basal situation Post w-3 PUFAs supplementation p Value
Body mass index, Kg/m 2 26.1 (24.0-28.0) 26.3 (24.1-27.9) 0.753
Waist circunference, cm 95.0 (87.1-98.5) 95.0 (87.0-101) 0.785
Systolic blood pressure, mmHg 134 (115–139) 122 (107–129) 0.042
Dyastolic blood pressure, mmHg 78.0 (67.7-85.5) 77.5 (67.7-81.7) 0.109
Total cholesterol, mg/dL 208 (186–232) 214 (190–249) 0.345
LDL cholesterol, mg/dL 136 (104–170) 144 (107–184) 0.173
HDL cholesterol, mg/dL 49.0 (41.0-61.5) 49.0 (45.7-59.2) 0.496
Non-HDL cholesterol, mg/dL 155 (122–191) 162 (122–205) 0.528
Triglycerides, mg/dL 92.5 (74.2-127) 92.0 (77.2-111) 0.500
Apo A-I, mg/dL 143 (136–166) 150 (146–162) 0.893
Apo B, mg/dL 111 (90.6-145) 109 (86.8-139) 0.116
Lp(a), mg/dL 57.3 (16.3-59.1) 35.5 (16.3-66.7) 0.273
CRP, mg/L 2.55 (1.47-4.45) 3.45 (0.80-5.20) 0.345
Creatinine, mg/dL 0.86 (0.82-0.99) 0.94 (0.74-1.04) 0.686
Glucose, mg/dL 87.5 (79.0-93.5) 78.5 (71.2-92.0) 0.043
  1. Variables are expressed as median (interquartile range). Apo denotes apolipoprotein. CRP denotes C Reactive Protein.